144 related articles for article (PubMed ID: 34389004)
1. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer in Puerto Rico.
Quiñones-Avila V; Ortiz-Ortiz KJ; Ríos-Motta R; Marín-Centeno H; Tortolero-Luna G
BMC Palliat Care; 2021 Aug; 20(1):127. PubMed ID: 34389004
[TBL] [Abstract][Full Text] [Related]
2. Underuse of Radiation Therapy After Breast Conservation Surgery in Puerto Rico: A Puerto Rico Central Cancer Registry-Health Insurance Linkage Database Study.
Chance WW; Ortiz-Ortiz KJ; Liao KP; Zavala Zegarra DE; Stauder MC; Giordano SH; Tortolero-Luna G; Guadagnolo BA
J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241162
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
Chen AB; Cronin A; Weeks JC; Chrischilles EA; Malin J; Hayman JA; Schrag D
J Clin Oncol; 2013 Feb; 31(5):558-64. PubMed ID: 23295799
[TBL] [Abstract][Full Text] [Related]
4. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer.
Hayman JA; Abrahamse PH; Lakhani I; Earle CC; Katz SJ
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1001-7. PubMed ID: 17689029
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
Koshy M; Malik R; Mahmood U; Husain Z; Weichselbaum RR; Sher DJ
J Natl Cancer Inst; 2015 Dec; 107(12):djv278. PubMed ID: 26424779
[TBL] [Abstract][Full Text] [Related]
6. The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.
Chiang Y; Yang JC; Hsu FM; Chen YH; Shih JY; Lin ZZ; Lan KH; Cheng AL; Kuo SH
PLoS One; 2015; 10(12):e0145936. PubMed ID: 26720170
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic, clinical characteristics, and treatment patterns of endometrial cancer cases in Puerto Rico during the period 2009 to 2015: A retrospective study.
Pagán Santana Y; Castañeda Ávila M; Ríos Motta R; Ortiz Ortiz KJ
PLoS One; 2024; 19(5):e0302253. PubMed ID: 38696411
[TBL] [Abstract][Full Text] [Related]
8. Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis.
Fraser I; Lefresne S; Regan J; Berthelet E; Chooback N; Ho C; Olson R
Lung Cancer; 2019 Sep; 135():97-103. PubMed ID: 31447009
[TBL] [Abstract][Full Text] [Related]
9. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
Mac Manus MP; Matthews JP; Wada M; Wirth A; Worotniuk V; Ball DL
Cancer; 2006 Mar; 106(5):1110-6. PubMed ID: 16432830
[TBL] [Abstract][Full Text] [Related]
10. Utilization pattern and service settings of palliative care for patients with metastatic non-small cell lung cancer.
Huo J; Hong YR; Turner K; Bian J; Grewal R; Wilkie DJ
Cancer; 2019 Dec; 125(24):4481-4489. PubMed ID: 31449674
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer.
Coy P; Schaafsma J; Schofield JA
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1025-33. PubMed ID: 11072159
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.
Macbeth FR; Bolger JJ; Hopwood P; Bleehen NM; Cartmell J; Girling DJ; Machin D; Stephens RJ; Bailey AJ
Clin Oncol (R Coll Radiol); 1996; 8(3):167-75. PubMed ID: 8814371
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung Cancer.
Zhao F; Ding G; Huang W; Li M; Fu Z; Yang G; Kong L; Zhang Y; Yu J
Clin Lung Cancer; 2015 Nov; 16(6):e111-9. PubMed ID: 25736696
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Inflammatory Breast Cancer in Hispanic Women from Puerto Rico.
Quirindongo-Rivera C; Rullán-Varela V; Underill Z; Rivera M; Ortiz-Ortiz KJ; Martínez-Montemayor MM
J Cancer; 2022; 13(14):3495-3502. PubMed ID: 36484009
[No Abstract] [Full Text] [Related]
15. Best supportive care in non-small cell lung cancer: is there a role for radiotherapy and chemotherapy?
Numico G; Russi E; Merlano M
Lung Cancer; 2001 Jun; 32(3):213-26. PubMed ID: 11390003
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database.
Bates JE; Morris CG; Milano MT; Yeung AR; Hoppe BS
Radiother Oncol; 2019 Sep; 138():75-79. PubMed ID: 31252297
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy for brain metastases near the end of life in an integrated health care system.
Ryoo JJ; Batech M; Zheng C; Kim RW; Gould MK; Kagan AR; Lien WW
Ann Palliat Med; 2017 Aug; 6(Suppl 1):S28-S38. PubMed ID: 28595434
[TBL] [Abstract][Full Text] [Related]
18. Metastatic non-small cell lung cancer: a benchmark for quality end-of-life cancer care?
Philip J; Hudson P; Bostanci A; Street A; Horey DE; Aranda S; Zordan R; Rumbold BD; Moore G; Sundararajan V
Med J Aust; 2015 Feb; 202(3):139-43. PubMed ID: 25669476
[TBL] [Abstract][Full Text] [Related]
19. Palliative Thoracic Radiotherapy for Non-small Cell Lung Cancer: Is There any Impact of Target Volume Size on Survival?
Nieder C; Imingen KS; Mannsaker B; Yobuta R
Anticancer Res; 2021 Jan; 41(1):355-358. PubMed ID: 33419831
[TBL] [Abstract][Full Text] [Related]
20. Response of global quality of life to high-dose palliative radiotherapy for non-small-cell lung cancer.
Schaafsma J; Coy P
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):691-701. PubMed ID: 10837953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
